Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Michael Kauffman

Affiliations

  • Chief Executive Officer at Karyopharm Therapeutics Inc. (KPTI), 2019-11-12
  • Director at Kezar Life Sciences Inc. (KZR), 2019-06-27
  • Director at Verastem Inc. (VSTM), 2019-06-26
  • Director at Infinity Pharmaceuticals Inc. (INFI), 2019-06-14
  • Director at Zalicus Inc. (ZLCS), 2013-06-10
  • Chief Medical Officer at Onyx Pharmaceuticals Inc (ONXX), 2010-02-11
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VSTM $7.49 4,000 Director 4,000 2018-09-28 Filing
VSTM $9.10 3,000 Director 3,000 2014-09-17 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KPTI $14.63 10,000 Officer, Director 731,134 2019-11-08 Filing
KPTI $14.76 10,000 Officer, Director 529,767 2019-11-11 Filing
KPTI $12.00 10,000 Officer, Director 731,134 2019-11-01 Filing
KPTI $12.00 10,000 Officer, Director 529,767 2019-11-01 Filing
KPTI $12.00 10,000 Officer, Director 731,134 2019-09-16 Filing